TBIQYR5174-Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Research Report 2019
- TBI241394
- February 11, 2019
- Global
- 99 pages
- QY Market Research
Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of Willis is the area at the base of the brain that joins these arteries.
The classification of ICAD (Intracranial Atherosclerotic Disease) Pathology includes Stent and PTA Balloon, and the proportion of Stent in 2017 is about 80.15%.
ICAD (Intracranial Atherosclerotic Disease) Pathology is widely used in Hospital, Clinic and other field. The most proportion of ICAD (Intracranial Atherosclerotic Disease) Pathology is Hospital, and the consumption proportion in 2017 is about 63%.
North America is the largest Sales place, with a Sales market share nearly 26% in 2017. Following North America, Europe is the second largest Sales place with the Sales market share of 20%.
Market competition is intense. Stryker, Balt, TERUMO, MicroPort, Acandis, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The global ICAD (Intracranial Atherosclerotic Disease) Pathology market is valued at 130 million US$ in 2018 is expected to reach 260 million US$ by the end of 2025, growing at a CAGR of 8.8% during 2019-2025.
This report focuses on ICAD (Intracranial Atherosclerotic Disease) Pathology volume and value at global level, regional level and company level. From a global perspective, this report represents overall ICAD (Intracranial Atherosclerotic Disease) Pathology market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Stryker
Balt
TERUMO
MicroPort
Acandis
...
Segment by Regions
North America
Europe
China
Japan
Segment by Type
primarily split into
Stent
PTA Balloon
Segment by Application
Hospital
Clinic
Other
Table of Contents
Executive Summary
1 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Overview
1.1 Product Overview and Scope of ICAD (Intracranial Atherosclerotic Disease) Pathology
1.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Segment by Type
1.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Production Growth Rate Comparison by Type (2014-2025)
1.2.2 primarily split into
1.2.3 Stent
1.2.4 PTA Balloon
1.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Segment by Application
1.3.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Consumption Comparison by Application (2014-2025)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market by Region
1.3.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Region
1.3.2 North America Status and Prospect (2014-2025)
1.3.3 Europe Status and Prospect (2014-2025)
1.3.4 China Status and Prospect (2014-2025)
1.3.5 Japan Status and Prospect (2014-2025)
1.3.6 Southeast Asia Status and Prospect (2014-2025)
1.3.7 India Status and Prospect (2014-2025)
1.4 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size
1.4.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue (2014-2025)
1.4.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Production (2014-2025)
2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Competition by Manufacturers
2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Production Market Share by Manufacturers (2014-2019)
2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Manufacturers (2014-2019)
2.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Average Price by Manufacturers (2014-2019)
2.4 Manufacturers ICAD (Intracranial Atherosclerotic Disease) Pathology Production Sites, Area Served, Product Types
2.5 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Competitive Situation and Trends
2.5.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Concentration Rate
2.5.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Production Market Share by Regions
3.1 ...
| read more...
Related Reports
